Charles River Laboratories | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agilent USD 1.54B 49M 2025-07
Align Technology USD 873.01M 170.88M 2025-03
Bio-Rad Laboratories USD 369.3M 152.1M 2025-06
Bruker USD 92M 92.2M 2025-06
Cardinal Health USD 3.87B 548M 2025-06
Charles River Laboratories USD 182.82M 46.53M 2025-06
Cigna USD 4.33B 4B 2025-06
CVS Health USD 11.79B 1.71B 2025-06
Danaher USD 2.96B 964M 2025-06
Dentsply International USD 359M 39M 2025-06
Elevance Health USD 8.56B 1.06B 2025-06
Galapagos EUR 108.07M 43.83M 2025-03
Hologic USD 1.74B 305.7M 2025-06
Humana USD 4.04B 210M 2025-06
Illumina USD 934M 179M 2025-06
Incyte USD 2.42B 13.08M 2025-06
IQVIA Holdings USD 2.04B 299M 2025-06
Laboratory Of America USD 647.3M 277.9M 2025-06
Lonza CHF 1.11B 286M 2024-12
McKesson USD 2.42B 3.27B 2025-06
Merck EUR 1.17B 161M 2025-06
Mettler Toledo International USD 61.82M 2.47M 2025-06
Novartis USD 6.66B 410M 2025-06
Pfizer USD 1.64B 208M 2025-06
Quest Diagnostics USD 319M 131M 2025-06
Revvity USD 991.85M 145.77M 2025-06
Thermo Fisher Scientific USD 4.58B 442M 2025-06
United Therapeutics USD 1.59B 306.8M 2025-06
UnitedHealth USD 32.02B 2.27B 2025-06
Waters USD 367.22M 15.66M 2025-06
West Pharmaceutical Services USD 509.7M 105.5M 2025-06


Charles River Laboratories Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.